Testing effectiveness (Phase 2)Ended earlyNCT02633540
What this trial is testing
Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function
Who this might be right for
Laryngeal Neoplasms
Fox Chase Cancer Center 2